The Role of Supraciliary MIGS in the Glaucoma Treatment Paradigm

Show Description +

I. Paul Singh, MD, describes where the MINIject (iStar Medical) supraciliary MIGS device fits into his glaucoma treatment paradigm. He explains the limitations of trabecular meshwork-based MIGS devices and shares his clinical experience with the MINIject, discussing the device’s safety and efficacy. He further describes the ideal patient for the MINIject to significantly reduce a patient’s drop burden.

Posted: 11/19/2024

Up Next

Consider the Supraciliary Space With MINIject

Joseph F. Panarelli, MD; and I. Paul Singh, MD


Question and Answer: MINIject Supraciliary MIGS Device

Joseph F. Panarelli, MD; Leon Au, BSc, MBBS, FRCOphth; and Tim Schultz, MD, PhD, FEBO

STAR-GLOBAL 3-Year Results

I. Paul Singh, MD

Q&A: MINIject Supraciliary MIGS Device

Steven R. Sarkisian Jr, MD; Karsten Klabe, MD; Faisal Ahmed, MD; and I. Paul Singh, MD

Full Webinar: An Eye-Opening Update on MIGS

Inder Paul Singh, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Julián García-Feijoó, MD, PhD, Philippe Denis, MD, PhD

European STAR-II Trial Results at One Year

Julián García-Feijoó, MD, PhD

Webinar Part 1: Where Do We Stand With MIGS?

Iqbal Ike K. Ahmed, MD, FRCSC

Webinar Part 2: How Can We Leverage the Power of the Supraciliary Space?

Julián García-Feijoó, MD, PhD, Philippe Denis, MD, PhD, Inder Paul Singh, MD, Iqbal Ike K. Ahmed, MD, FRCSC

Webinar Part 3: The MINIject™ Next-Generation Supraciliary Device

Inder Paul Singh, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Julián García-Feijoó, MD, PhD, Philippe Denis, MD, PhD

Webinar Part 6: Clinical Trial Results Q&A and Next Steps

Inder Paul Singh, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Julián García-Feijoó, MD, PhD, Philippe Denis, MD, PhD

Enhanced and Sustained IOP reduction with MINIject

Iqbal Ike K. Ahmed, MD, FRCSC, Michel Vanbrabant, Steven Vold, MD

The Role of Supraciliary MIGS in the Glaucoma Treatment Paradigm

I. Paul Singh, MD, describes where the MINIject (iStar Medical) supraciliary MIGS device fits into his glaucoma treatment paradigm. He explains the limitations of trabecular meshwork-based MIGS devices and shares his clinical experience with the MINIject, discussing the device’s safety and efficacy. He further describes the ideal patient for the MINIject to significantly reduce a patient’s drop burden.

Posted: 11/19/2024

About iSTAR Medical

Visit us online: istarmed.com

Follow iSTAR Medical